Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 48 of 56
The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.
Pitch deck · roadmap · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 framework 1/1 table 1/1 title 1/1
Components 4
primary instance data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1